As a dual GIP and GLP-1 receptor agonist, it works by reducing appetite, slowing gastric emptying, and helping people feel fuller for longer
New medications under FDA review, such as dual and triple agonists, are showing 20-30% weight loss in trials, monthly dosing options, and more flexible oral formulations are all in late-stage development
Hims Semaglutide is a compounded medication containing semaglutide, the active ingredient found in the FDA-approved weight loss drug Wegovy, offered through the Hims & Hers telehealth platform
The CDSCO has quickly come out with rules to prevent this misuse and that is very welcome
These innovative formulations combine the advanced bioavailability of liposomal technology with the convenience and stability of tablet form, making it easier than ever to incorporate glutathione supplementation into daily wellness routines
Over six months, that adds up to $600 in savings